Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Jeff Stolte
AddedMar 31, 2024
UpdatedMay 1, 2026
Jeff Stolte

Jeff Stolte

Board Member, SpineZone

Jeff Stolte's Career

SpineZone
SpineZone

San Diego, CA, US

Board Member· Board
Intelligent Retinal Imaging Systems
Intelligent Retinal Imaging Systems

Pensacola, FL, US

Board Member· Board
Trilliant Health
Trilliant Health

Brentwood, TN, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Jeff Stolte's Career

SpineZone
SpineZone
Series A$12M732014San Diego, CA, US
Board Member· Board

Leadership at SpineZone

Kamshad RaiszadehKamshad RaiszadehBoard Member

Similar to SpineZone

Medx Back Pain Clinics.Medx Back Pain Clinics.North Palm Beach, FL, USBack Pain Treatment, Healthcare, Pain Management, Rehabilitation Services, Spinal Healthest. 2023Medx Back Pain Clinics.North Palm Beach, FL, US · est. 2023

Florida-based MedX Back Pain Clinics provides lumbar strengthening solutions for lower back pain.

Seed · $1k50
Therasport Physical TherapyTherasport Physical TherapySewell, NJ, USPhysical Therapyest. 2012Therasport Physical TherapySewell, NJ, US · est. 2012

Therasport Physical Therapy, Inc. offers personalized care for orthopedic and neurological conditions, based in California.

Seed · $50k5
EgoscueEgoscueSan Diego, CA, USPain Reliefest. 1971EgoscueSan Diego, CA, US · est. 1971

Egoscue, a biotech firm, develops natural, non-medical pain relief solutions.

Seed · $12.6k38
Spine WaveSpine WaveShelton, CT, USMedical Devicesest. 2001Spine WaveShelton, CT, US · est. 2001

US-based Spine Wave develops and markets medical devices for spinal disorder treatments.

Series A · $145.5M122
Intelligent Retinal Imaging Systems
Intelligent Retinal Imaging Systems
Series A$13.3M392011Pensacola, FL, US
Board Member· Board

Leadership at Intelligent Retinal Imaging Systems

Matt RiceMatt RiceBoard Member
Jamo Rubin, MDJamo Rubin, MDBoard Member
Sunil GuptaSunil GuptaBoard Member
Steve MartinSteve MartinCEO

Similar to Intelligent Retinal Imaging Systems

Retina TechnologiesRetina TechnologiesNew York City, NY, USMedical Devicesest. 2018Retina TechnologiesNew York City, NY, US · est. 2018

Retina Technologies: Making vision screening accessible with portable, modular medical devices.

Pre-Seed · $333k8
Ai-RisAi-RisCollege Station, TX, USMedical Devicesest. 2020Ai-RisCollege Station, TX, US · est. 2020

AI-Ris provides automated retinal exams via a portable headset, using machine learning for primary care.

Angel · $255.9k5
Bioxytech RetinaBioxytech RetinaRichmond, CA, USMedical Devicesest. 2015Bioxytech RetinaRichmond, CA, US · est. 2015

Bioxytech Retina, founded in 2015, pioneers non-invasive optical devices for diabetes diagnosis.

Pre-Seed · $1.2M5
Retina-Ai HealthRetina-Ai HealthHouston, TX, USAI Software, Healthcareest. 2017Retina-Ai HealthHouston, TX, US · est. 2017

AI Healthcare provider transforming the industry with innovative technology.

Seed · $12.8M8
Trilliant Health
Trilliant Health
Series A$12M1212017Brentwood, TN, US
Board Member· Board

Leadership at Trilliant Health

Tony CorleyTony CorleyBoard Member
Lori CopelandLori CopelandBoard Member
Devin CartyDevin CartyFounder
Hal AndrewsHal AndrewsBoard Member
Henry RossHenry RossBoard Member

Similar to Trilliant Health

Trella HealthTrella HealthAtlanta, GA, USCRM, Market Insightsest. 2015Trella HealthAtlanta, GA, US · est. 2015

Trella Health offers comprehensive care-activity mapping for acute, ambulatory, and post-acute organizations.

Private Equity · $5.2M95
TraytTraytRedwood City, CA, USHealthcare Softwareest. 2013TraytRedwood City, CA, US · est. 2013

Trayt: Streamlining healthcare with enterprise software for enhanced brain disorder treatments.

Series A · $9.8M25
Health CatalystHealth CatalystSalt Lake City, UT, USData Analyticsest. 2008Health CatalystSalt Lake City, UT, US · est. 2008

Health Catalyst: Leading provider of data analytics technology for measurable healthcare improvement.

Public · $440.5M1.2k
Real Time Medical SystemsReal Time Medical SystemsLinthicum Heights, MD, USHealthcare Analyticsest. 2011Real Time Medical SystemsLinthicum Heights, MD, US · est. 2011

Real Time Medical Systems: Enhancing patient care through healthcare interventional analytics.

Series C · $29.7M83

Jeff Stolte's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · Kakao

People Similar to Jeff Stolte

Andrew WhiteAndrew WhiteBoard Member · TrilliantMatthew TrerotolaMatthew TrerotolaBoard Member · ColfaxJan-Luuk De GrootJan-Luuk De GrootBoard Member · Health InnovationsXander SchrageXander SchrageBoard Member · Health Innovations